Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Xiaoping Zhang, Ya-Chi Chen & Kimio Terao. (2017) Clinical pharmacology of tocilizumab for the treatment of polyarticular-course juvenile idiopathic arthritis. Expert Review of Clinical Pharmacology 10:5, pages 471-482.
Read now
Read now
Tsutomu Takeuchi, Yoshiya Tanaka, Hisashi Yamanaka, Kanzo Amano, Ryuji Nagamine, Won Park, Kazuko Shiozawa, Michishi Tsukano, James Cheng-Chung Wei, Jing Shao, Osamu Togo & Hideki Mashimo. (2016) Efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: Results from a randomized phase II trial. Modern Rheumatology 26:1, pages 15-23.
Read now
Read now
Eiichi Tanaka, Eisuke Inoue, Daisuke Hoshi, Yoko Shimizu, Akiko Kobayashi, Naoki Sugimoto, Kumi Shidara, Eri Sato, Yohei Seto, Ayako Nakajima, Shigeki Momohara, Atsuo Taniguchi & Hisashi Yamanaka. (2015) Cost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort study. Modern Rheumatology 25:4, pages 503-513.
Read now
Read now
Israa Al-Shakarchi, Nicola J Gullick & David L Scott. (2013) Current perspectives on tocilizumab for the treatment of rheumatoid arthritis: a review. Patient Preference and Adherence 7, pages 653-666.
Read now
Read now
Xiaoping Zhang, Peter N Morcos, Tomohisa Saito & Kimio Terao. (2013) Clinical pharmacology of tocilizumab for the treatment of systemic juvenile idiopathic arthritis. Expert Review of Clinical Pharmacology 6:2, pages 123-137.
Read now
Read now
Shunsuke Mori, Kaoru Terada & Yukitaka Ueki. (2012) Tocilizumab-induced hyperbilirubinemia in Japanese patients with rheumatoid arthritis: its association with UDP glucuronosyltransferase 1A1 gene polymorphisms. Modern Rheumatology 22:4, pages 515-523.
Read now
Read now
Shunsuke Mori & Yukitaka Ueki. (2011) Primary lack of efficacy of infliximab therapy for rheumatoid arthritis: pharmacokinetic characterization and assessment of switching to tocilizumab. Modern Rheumatology 21:6, pages 628-636.
Read now
Read now
Xiaoping Zhang & Richard Peck. (2011) Clinical pharmacology of tocilizumab for the treatment of patients with rheumatoid arthritis. Expert Review of Clinical Pharmacology 4:5, pages 539-558.
Read now
Read now
Matthew B Carroll. (2011) The impact of biologic response modifiers on hepatitis B virus infection. Expert Opinion on Biological Therapy 11:4, pages 533-544.
Read now
Read now
Amr A Saad, Kimme L Hyrich & Darren M Ashcroft. (2011) Drug persistence, effectiveness and safety assessment of anti-TNF therapies in psoriatic arthritis. Expert Opinion on Drug Safety 10:2, pages 219-226.
Read now
Read now
Articles from other publishers (2)
E. Feist, S. Fatenejad, S. Grishin, E. Korneva, M.E. Luggen, E. Nasonov, M. Samsonov, J.S. Smolen & R.M. Fleischmann. (2023) Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study. Modern Rheumatology Journal 17:2, pages 23-26.
Crossref
Crossref
A. A. Godzenko, E. V. Cheremushkina, A. E. Dimitreva & M. M. Urumova. (2021) Combination of ankylosing spondylitis and rheumatoid arthritis: clinical observations and literature review. Modern Rheumatology Journal 15:4, pages 72-80.
Crossref
Crossref